Established in 1958, Qilu Pharmaceutical is a leading vertically integrated pharmaceutical company in China, with extensive capabilities in drug development, manufacturing, and commercialization. With more than 38,000 employees worldwide, Qilu provides medicines to over 110 countries and regions.

Since 2015, Sound Biologics and Qilu Pharmaceutical have maintained a strategic partnership in the development and manufacturing of innovative antibody therapeutics.